Cancer Center Administration

项目概要/摘要 马基癌症中心（MCC）行政部门为MCC主任提供有效的行政支持， 高级领导，研究项目负责人，共享资源基金（SRF）主任和MCC成员。 行政部门通过以下具体目标促进卓越的科学和影响：1）领导MCC的 2）通过方案间和方案内活动促进协作， 投资和利用资源和基础设施; 3）支持MCC的综合研究， 教育、社区外展以及多样性、公平和包容活动;以及4）支持可持续性和 业务规划。在本报告所述期间，行政部门通过以下方式促进了成员科学： 1)制定了新的24 -28财年MCC战略计划，该计划与6440万美元的财务承诺相结合， 英国领导层对癌症中心的投资; 2）协助MCC的研究重组 3）在关键领域扩大MCC的研究传播办公室，以继续大力支持 CCSG相关活动; 4）推动MCC的临床方案和数据管理团队扩大128%， 这为干预性治疗试验增加56%铺平了道路; 5）监督78%的 MCC的物理空间扩大，从128，587平方米增加到2000平方米。英尺至228，237平方米英尺自2009年以来; 6） 促进MCC的所有试点和种子奖励计划，自2018年以来已向调查人员颁发了220万美元; 7)简化会员申请和审查程序;以及8）改善MCC的内部和外部 沟通渠道，从升级MCC面向公众的网站到建立新的渠道 员工领导之间的内部沟通。为了加强对癌症的关注，政府设立了 实施了一项全中心范围的政策，以确定数据中列出的所有赠款和合同的癌症相关性 表2.这些努力共同支持了自2017年以来1110万美元的同行评审资金的增加， 新增66名癌症中心成员。在未来五年，政府会与 MCC主任和高级领导人：1）实施和评估中心的FY 24 -28战略计划; 2） 实施计划中的MCC能力扩展，以领导多中心临床试验，这代表了 该中心承诺提供220万美元，以建立这种新的能力; 3）扩大多样性，公平性和包容性 努力通过改进MCC的教师和工作人员的招聘和保留的做法，并评估 成功; 4）扩大报告和分析能力，通过 实施CCSG数据和电子监管系统;以及5）促进 先进的门诊大楼，现场工作定于2022年秋季末开始。通过强有力的规划 管理部门将领导管理协委会职能的调整，以支持中心的目标， 获得综合癌症中心的地位。

PROJECT SUMMARY/ABSTRACT Markey Cancer Center (MCC) Administration provides efficient administrative support to MCC’s Director, Senior Leadership, Research Program leaders, Shared Resource Facility (SRF) directors and MCC members. Administration fosters exceptional science and impact through the following Specific Aims: 1) Lead MCC’s planning and evaluation efforts; 2) Foster collaboration through inter- and intra-programmatic activities and investing in and leveraging resources and infrastructure; 3) Support MCC’s comprehensive research, education, community outreach, and diversity, equity and inclusion activities; and 4) Support sustainability and business planning. During the current reporting period, Administration has facilitated member science through: 1) creating a new FY24-28 MCC Strategic Plan, which is coupled with a $64.4M financial commitment and investment from UK Leadership in the cancer center; 2) assisting in the restructuring of MCC’s Research Programs; 3) expanding MCC’s Research Communications Office in key areas to continue robust support of CCSG-related activity; 4) driving a 128% expansion of MCC’s Clinical Protocol and Data Management teams, which paved the way for a 56% increase in accruals to interventional treatment trials; 5) overseeing a 78% expansion of MCC’s physical space, which has grown from 128,587 sq. ft. to 228,237 sq. ft. since 2009; 6) facilitating all MCC’s pilot and seed award programs, which have awarded $2.2M to investigators since 2018; 7) streamlining the membership application and review process; and 8) improving MCC’s internal and external communication channels, ranging from upgrades to MCC’s public-facing website to establishing new channels for internal communication among staff leaders. To enhance cancer focus, Administration created and implemented a center-wide policy on determining cancer-relatedness of all grants and contracts listed on Data Table 2. Together, these efforts supported an increase in peer-reviewed funding of $11.1M since 2017 and the addition of 66 new cancer center members. Over the coming five years, Administration will work closely with the MCC Director and Senior Leaders to: 1) implement and evaluate the center’s FY24-28 Strategic Plan; 2) implement the planned expansion of MCC’s capabilities to lead multi-site clinical trials, which represents a $2.2M commitment from the center to build out this new competency; 3) expand diversity, equity and inclusion efforts through improvements to MCC’s faculty and staff recruitment and retention practices, and evaluating success; 4) expand reporting and analysis capabilities and achieve greater efficiency through the implementation of CCSG data and electronic regulatory systems; and 5) facilitate planning efforts for an advanced ambulatory building, site work for which is slated to begin in late fall 2022. Through robust planning and evaluation efforts, Administration will lead the alignment of MCC functions in support of the center’s goal of achieving Comprehensive Cancer Center status.